Kate Cronin, Global CEO of Ogilvy Health, shares her views on a variety of healthcare industry topics in a Q&A with PharmaLive.
We are well into the global pandemic that has disrupted our professional and personal lives. This is a once in a lifetime paradigm shift – we have adjusted much of our day to day BUT where does clinical site contracting and budgeting fall?
How NPP Is Changing With the Onset of COVID-19
Artificial Intelligence, At-Home Testing, Behavioral Changes, Conferences, Coronavirus Disease (COVID-19) Pandemic, Digital, Doctors, Electronic Health Records, HCPs, Health Insurance, Healthcare Communications Agencies, Marketing & Advertising, Physicians, Sales Forces, Sales Reps, Social Media, Telemedicine, Trends, VeevaGreater Than One’s Christa Toole analyzes how healthcare marketers are adjusting to the current health crisis in a variety of ways.
Join the Marken team and industry experts to learn about new supply chain industry trends and how companies can prepare to move clinical trials forward post-pandemic.
Innovation Week at FCB Health focuses on tech advances in healthcare advertising
Customers, Departments, Facebook, Google, Healthcare, Healthcare Communications Agencies, Healthcare Communications Networks, Innovation, Issue Archives, June 2019, Med Ad News, Medicine Avenue, Patients, Trends, Veeva, Voice AssistantsFCB Health Network held its annual Innovation Week from May 7-9, 2019. Here’s a topline summary for anyone who missed the event.
The IQVIA Institute for Human Data Science is releasing the 2019 “Global Oncology Trends” report simultaneously with the American Society of Clinical Oncology (ASCO) Meeting.
Klick Inc., a six-time-and-counting 2019 Best Workplace award recipient, is rewriting the book on employee engagement.
EVERSANA unveiled Health Strategies Insights by EVERSANA, a comprehensive market access research and insights portfolio to help life science innovators make more informed decisions.
7 Biotech Trends to Look Out for in 2019
Alzheimer's Diseases, Analysts, Business, Cancer, CAR-T Therapy, Clinical Trials, CRISPR/Cas9, Department of Health and Human Services (HHS), Drug Pricing, FDA, Immuno-oncology, Initial Public Offering (IPO), National Institutes of Health, Opioids, Politics, R&D, Spinal Muscular Atrophy (SMA), Therapeutics, TrendsHere are seven trends most likely to be hitting the news cycle in 2019 according to BioSpace.
Barring a last-minute reversal, 2018 will likely end as a down year for the biotech industry, at least in terms of stock performance.